REDULEN Trademark

Trademark Overview


On Tuesday, April 5, 2022, a trademark application was filed for REDULEN with the United States Patent and Trademark Office. The USPTO has given the REDULEN trademark a serial number of 79342473. The federal status of this trademark filing is REGISTERED as of Tuesday, October 10, 2023. This trademark is owned by ESSERRE PHARMA SRL. The REDULEN trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements for the cardio-metabolic and cardiovascular area; pharmaceuticals for the cardio-metabolic and cardiovascular area; dietetic foods adapted for medical purposes
redulen

General Information


Serial Number79342473
Word MarkREDULEN
Filing DateTuesday, April 5, 2022
Status700 - REGISTERED
Status DateTuesday, October 10, 2023
Registration Number7185124
Registration DateTuesday, October 10, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesDietary supplements for the cardio-metabolic and cardiovascular area; pharmaceuticals for the cardio-metabolic and cardiovascular area; dietetic foods adapted for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameESSERRE PHARMA SRL
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIT

Party NameESSERRE PHARMA SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIT

Party NameESSERRE PHARMA SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIT

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, January 13, 2024FINAL DISPOSITION NOTICE SENT TO IB
Saturday, January 13, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 10, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 19, 2023REFUSAL PROCESSED BY IB
Tuesday, March 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 27, 2023REFUSAL PROCESSED BY MPU
Tuesday, January 31, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 30, 2023NON-FINAL ACTION WRITTEN
Monday, January 23, 2023ASSIGNED TO EXAMINER
Tuesday, June 21, 2022APPLICATION FILING RECEIPT MAILED
Friday, June 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 16, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB